2 studies found for: "Multiple endocrine neoplasia type 2B"
|1||Active, not recruiting||
Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer
|2||Not yet recruiting||
Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine Tumor
† Study has passed its completion date and status has not been verified in more than two years.